Interferon gamma and interleukin-2 secretion in whole blood cell cultures from small-cell lung cancer patients

被引:4
作者
Szopinski, J
von Kleist, S
Rowinska-Zakrzewska, E
Panorska, A
Roginska, E
Rogala, E
机构
[1] Natl TB & Lung Dis Res Inst, PL-01138 Warsaw, Poland
[2] Univ Freiburg, Inst Immunobiol, D-7800 Freiburg, Germany
[3] BlueCross BlueShield Tennessee, Chattanooga, TN USA
关键词
small-cell lung cancer; interferon-gamma; interleukin-2;
D O I
10.1159/000050599
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Secretion of interleukin-2 (IL-2) and interferon-gamma (IFN gamma) in whole blood cell cultures after phytohemagglutinin (PHA) and pokeweed mitogen (PWM) stimulation was evaluated in 42 small-cell lung cancer patients before treatment. Blood cultures from patients with extensive and limited disease have lower IFN gamma secretions after PWM stimulation and tower IL-2 secretions after PWM and PHA stimulation, but this was not statistically significant. IFN gamma but not IL-2 secretion was significantly higher after PWM stimulation in cultures from patients with better clinical performance status (0 + 1,WHO scale). Blood cultures from patients with tumor regression after treatment had a higher secretion of IFN gamma after PWM stimulation. In contrast, blood cultures from patients with a poor prognosis had significantly lower IL-2 and IFN gamma secretions after stimulation with PWM, and a lower IL-2 secretion after stimulation with PHA. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:72 / 76
页数:5
相关论文
共 31 条
[1]   DETERMINANTS OF IMPROVED OUTCOME IN SMALL-CELL LUNG-CANCER - AN ANALYSIS OF THE 2,580-PATIENT SOUTHWEST ONCOLOGY GROUP DATA-BASE [J].
ALBAIN, KS ;
CROWLEY, JJ ;
LEBLANC, M ;
LIVINGSTON, RB .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (09) :1563-1574
[2]  
BUYSE ME, 1995, OXFORD TXB ONCOLOGY, P2377
[3]  
COHEN MH, 1981, CANCER TREAT REP, V65, P187
[4]  
DALBOW MH, 1977, J LAB CLIN MED, V90, P295
[5]  
ELSASSERBEILE U, 1993, CANCER, V71, P231, DOI 10.1002/1097-0142(19930101)71:1<231::AID-CNCR2820710136>3.0.CO
[6]  
2-3
[7]   IMPAIRED CYTOKINE PRODUCTION IN WHOLE-BLOOD CELL-CULTURES OF PATIENTS WITH GYNECOLOGICAL CARCINOMAS IN DIFFERENT CLINICAL STAGES [J].
ELSASSERBEILE, U ;
VONKLEIST, S ;
SAUTHER, W ;
GALLATI, H ;
MONTING, JS .
BRITISH JOURNAL OF CANCER, 1993, 68 (01) :32-36
[8]   EVALUATION OF A TEST SYSTEM FOR MEASURING CYTOKINE PRODUCTION IN HUMAN WHOLE-BLOOD CELL-CULTURES [J].
ELSASSERBEILE, U ;
VONKLEIST, S ;
GALLATI, H .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 139 (02) :191-195
[9]   IMPAIRED CYTOKINE PRODUCTION IN WHOLE-BLOOD CELL-CULTURES OF PATIENTS WITH UROLOGICAL CARCINOMAS [J].
ELSASSERBEILE, U ;
VONKLEIST, S ;
FISCHER, R ;
MARTIN, M ;
WETTERAUER, U ;
GALLATI, H ;
MONTING, JS .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1993, 119 (07) :430-433
[10]  
FILELLA X, 2000, IN PRESS TUMOR BIOL